Summary

Persistence Market Research has recently published an extensive report on the global Monkeypox (Mpox) Diagnosis Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

• Monkeypox (Mpox) Diagnosis Market Size (2024E): USD 1.95 Bn
• Projected Market Value (2031F): USD 2.4 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 4.4%

Monkeypox (Mpox) Diagnosis Market - Report Scope:

The Monkeypox Diagnosis Market encompasses diagnostic procedures that detect the presence of the monkeypox virus, a viral illness similar to smallpox but with generally milder symptoms. The market includes advanced diagnostic methods like molecular tests (PCR) and point-of-care testing (POCT) kits, with rising global awareness of monkeypox driving demand for improved diagnostic tools.

The resurgence of monkeypox outbreaks, particularly in 2022 and 2023, has fueled the need for rapid and accurate diagnostics. Specimens are often collected from skin lesions, as well as other samples such as throat swabs, blood, and bodily fluids. With advanced technologies, monkeypox diagnosis is now highly sensitive and reliable, meeting the healthcare industry's growing demand for non-invasive and precise diagnostic solutions.

Market Growth Drivers:

The growth of the global Monkeypox (Mpox) Diagnosis Market is primarily fueled by increasing global awareness and enhanced surveillance systems, especially following the major monkeypox outbreak in 2022. This heightened awareness has prompted governments and health organizations to invest in the necessary diagnostic infrastructure, enabling quicker detection and containment of the virus. Technological advancements have also played a significant role in propelling market growth.

Market Restraints:

Despite its promising growth potential, the Monkeypox (Mpox) Diagnosis Market faces several challenges that could impede expansion. One of the primary restraints is the limited healthcare infrastructure in developing regions, where diagnostic facilities and trained personnel are often lacking. This gap in resources restricts the widespread adoption of monkeypox diagnostic tools, particularly in areas that are more vulnerable to outbreaks due to high population density and proximity to wildlife reservoirs. Additionally, the regulatory environment poses significant challenges.

Market Opportunities:

The Monkeypox (Mpox) Diagnosis Market presents significant opportunities for growth, particularly in the expansion of point-of-care testing (POCT) solutions. As the demand for rapid and accessible diagnostic tools increases, POCT offers a viable solution for decentralized healthcare, enabling immediate results in remote or resource-limited areas. This shift toward portable, user-friendly diagnostic kits has the potential to revolutionize how infectious diseases like monkeypox are managed, leading to faster identification of cases and better outbreak containment.

Competitive Intelligence and Business Strategy:

Leading players in the global Monkeypox Diagnosis Market focus on innovation, R&D, and strategic partnerships with healthcare providers. Companies are investing in advanced diagnostic tools that ensure high accuracy and faster results. Collaborations with global healthcare organizations and expansion through e-commerce platforms are also driving market growth.

Key Market Players

• Abbott Laboratories
• Aegis Sciences Corporation
• Applied DNA Sciences, Inc.
• Becton, Dickinson and Company
• BioGX
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• CerTest Biotec
• Creative Biogene
• Danaher Corporation
• Flow Health
• Laboratory Corporation of America Holdings
• Mayo Clinic Laboratories
• Quest Diagnostics, Inc.
• Thermo Fisher Scientific Inc.

Market Segmentation

By Diagnostic Test

• Antigen Detection Test
• Molecular Test

By Sample

• Urine
• Whole Blood
• Skin lesion Specimen

By Region

• North America
• Latin America
• Europe
• South Asia & Oceania
• East Asia
• The Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Monkeypox (mpox) Diagnosis Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Diagnostic Test Adoption Analysis
3.2. Disease Epidemiology- Monkeypox (mpox)
3.3. Regulatory Landscape
3.4. Value Chain Analysis
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
3.7. Promotional Strategies, By Key Players
4. Global Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
4.3. Global Monkeypox (mpox) Diagnosis Market Outlook: Diagnostic Test
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Diagnostic Test, 2019-2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
4.3.3.1. Antigen Detection Test
4.3.3.2. Molecular Test
4.3.4. Market Attractiveness Analysis: Diagnostic Test
4.4. Global Monkeypox (mpox) Diagnosis Market Outlook: Sample
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Sample, 2019-2023
4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
4.4.3.1. Urine
4.4.3.2. Whole Blood
4.4.3.3. Skin Lesion Specimen
4.4.3.4. Others
4.4.4. Market Attractiveness Analysis: Sample
5. Global Monkeypox (mpox) Diagnosis Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
6.2.1. By Country
6.2.2. By Diagnostic Test
6.2.3. By Sample
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
6.4.1. Antigen Detection Test
6.4.2. Molecular Test
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
6.5.1. Urine
6.5.2. Whole Blood
6.5.3. Skin Lesion Specimen
6.5.4. Others
6.6. Market Attractiveness Analysis
7. Europe Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
7.2.1. By Country
7.2.2. By Diagnostic Test
7.2.3. By Sample
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkey
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
7.4.1. Antigen Detection Test
7.4.2. Molecular Test
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
7.5.1. Urine
7.5.2. Whole Blood
7.5.3. Skin Lesion Specimen
7.5.4. Others
7.6. Market Attractiveness Analysis
8. East Asia Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
8.2.1. By Country
8.2.2. By Diagnostic Test
8.2.3. By Sample
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
8.4.1. Antigen Detection Test
8.4.2. Molecular Test
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
8.5.1. Urine
8.5.2. Whole Blood
8.5.3. Skin Lesion Specimen
8.5.4. Others
8.6. Market Attractiveness Analysis
9. South Asia & Oceania Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
9.2.1. By Country
9.2.2. By Diagnostic Test
9.2.3. By Sample
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
9.4.1. Antigen Detection Test
9.4.2. Molecular Test
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
9.5.1. Urine
9.5.2. Whole Blood
9.5.3. Skin Lesion Specimen
9.5.4. Others
9.6. Market Attractiveness Analysis
10. Latin America Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
10.2.1. By Country
10.2.2. By Diagnostic Test
10.2.3. By Sample
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
10.4.1. Antigen Detection Test
10.4.2. Molecular Test
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
10.5.1. Urine
10.5.2. Whole Blood
10.5.3. Skin Lesion Specimen
10.5.4. Others
10.6. Market Attractiveness Analysis
11. Middle East & Africa Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
11.2.1. By Country
11.2.2. By Diagnostic Test
11.2.3. By Sample
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
11.4.1. Antigen Detection Test
11.4.2. Molecular Test
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
11.5.1. Urine
11.5.2. Whole Blood
11.5.3. Skin Lesion Specimen
11.5.4. Others
11.6. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping, By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Abbott Molecular, Inc.
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Laboratory Corporation of America (Labcorp)
12.3.3. Cue Health, Inc.
12.3.4. Quest Diagnostics Nichols Institute
12.3.5. Cepheid
12.3.6. DiaCarta, Inc.
12.3.7. Roche Molecular Systems, Inc.
12.3.8. Meridian Biosciences
12.3.9. Vazyme International LLC
12.3.10. Siemens Healthcare
12.3.11. MedTech Zone
12.3.12. Creative Biogene
12.3.13. Transasia diagnostics
12.3.14. JOYSBIO (Tianjin) Biotechnology Co., Ltd
12.3.15. Daan Gene Co., Ltd.
12.3.16. BD
12.3.17. CERTEST BIOTEC
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations